AIDS DRUG ASSISTANCE PROTOCOL
FUND
  ADAP Main Page

New and Noteworthy
 Prioritization Guidelines
 Funding Needs/Budgets
 Ethical Challenges   
Position Papers 
General Reports
 Conference Reports
 State Formularies
 State Challenges
NASTAD Reports
 Case Management

 

 Program Analyses 
Medicare and ADAP
Links  
Videos
Journal of Timely and Appropriate Care





 








 
 
US AIDS Drug Access Main Page    
LAST UPDATE  August 13, 2011
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     

August 2011
 
ADAP Funding Crisis on CN2
 

ADAP Funding/Budgets
       
General Reports
       
     Internet Document
 
 
FULL-TEXT PDF DOCUMENT
NASTAD ADAP Watch
NASTAD  June 04, 2009
 Internet Document

FULL-TEXT ARTICLE
 The Very Model of a Modern Major Modeler: An Interview with Kit N. Simpson, DrPH
 on her New Cost-of Care Model for HIV Care
 Simpson KN, Hawes J   
ADAP Fund/MedAdvocates
January 16, 2008
 Internet Document
 
 

    Journal Papers, Abstracts, and Commentaries
 
 
The Impact of the AIDS Drug Assistance Program (ADAP) on Use of Highly Active Antiretroviral and
Antihypertensive Therapy among HIV-Infected Women.
Yi T, Cocohoba J, Cohen M, et alJ
Acquir Immune Defic Syndr. 2010 Dec 25
 Abstract

Improving Outcomes in State AIDS Drug Assistance Programs.
Linas BP, Losina E, Rockwell A, et al 
J Acquir Immune Defic Syndr. 2009 Jun 25
 Abstract

AIDS Drug Assistance Programs in the Era of Routine HIV Testing.
Bassett IV, Farel C, Szmuilowicz ED, Walensky RP.
Clin Infect Dis. 2008 Jul 21.
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
Market power and state costs of HIV/AIDS drugs.
Leibowitz AA, Sood N.
Int J Health Care Finance Econ. 2007 May 5;
 Abstract
 
Optimizing resource allocation in United States AIDS drug assistance programs.
Linas BP, Zheng H, Losina E. et al
Clin Infect Dis. 2006 Nov 15;43(10):1357-64
 Abstract
 
The relationship between HAART use and employment for HIV-positive individuals:
an empirical analysis and policy outlook.
Bernell SL, Shinogle JA.  
Health Policy. 2005 Feb;71(2):255-64.
 Abstract
 
FULL-TEXT ARTICLE
 Advocate Profiles: William E. Arnold
Hinchey M  Darwell  W
JTAC January 2004
Paper

AIDS Drug Assistance Programs: highlighting inequities in human immunodeficiency
virus-infection health care in the United States.
Walensky RP, Paltiel AD, Freedberg KA.
Clin Infect Dis. 2002 Sep 1;35(5):606-10.
 Abstract
 
State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly
changing treatment standards.
Johri M, David Paltiel A, et al
Med Care. 2002 May;40(5):429-4
Abstract

'The AIDS drug assistance programs and coverage of HIV-related medications.
Smith SR, Buchanan RJ.
Ann Pharmacother 2001 Feb;35(2):155-66
Abstract
 

  
      Conference Reports, Abstracts, and Commentaries
 
  Access to HIV treatment, care and prevention from persons living with HIV/AIDS:
results of a comprehensive survey of ADAP recipients
 L.R. Frank, J. Folby, J. Pease
 (XVII International AIDS Conference)
 Abstract

     Internet Documents

 
Clinical outcomes of HIV-HCV co-infection in a large cohort of hemophiliac patients.
Lichterfeld M, Schmeisser N, Qurishi N,et al
J Infect. 2005 Apr;50(3):221-8.
Abstract
 
HIV and HCV coinfection in haemophilia.
 Wilde JT
 Haemophilia. 2004 Jan;10(1):1-8.
 Abstract
 
Progression of HIV infection and mortality by hepatitis C infection in patients with
haemophilia |over 20 years.
Quintana M, Del Amo J, Barrasa A, et al 
Haemophilia. 2003 Sep;9(5):605-12
 Abstract

Markers of HIV-1 disease progression in individuals with haemophilia coinfected with
hepatitis C  virus: a longitudinal study.
Sabin CA, Griffioen A, Yee TT, et al.
Lancet 2002 Nov 16;360(9345):1546-51
 Abstract

  

     Conference Reports, Abstracts, and Posters

  Viral Kinetic Modeling in HCV/HIV Co-infected Hemophiliacs Treated with Pegylated
Interferon  and Ribavirin
 Nhire, PS Horn, E M Eyster, et al.
 (11 CROI)
 Abstract
Women
Pregnant Women/Neonates

    Journal Papers, Abstracts, and Commentaries

 
CD8(+) T Cell Activation in Women Coinfected with Human Immunodeficiency Virus Type 1 and
Hepatitis C Virus.
 Kovacs A, Al-Harthi L, Christensen S, et al
J Infect Dis. 2008 May 15;197(10):1402-1407
 Abstract
 
Awareness of Hepatitis C Infection Among Women With and At Risk for HIV.
 Cohen MH, Grey D, Cook JA, et al 
J Gen Intern Med. 2007 Oct 9;
Abstract
 
Possible Compartmentalization of Hepatitis C Viral Replication in the Genital Tract of HIV-1-
Coinfected Women.
 Minosse C, Calcaterra S, Abbate I, et al
J Infect Dis. 2006 Dec 1;194(11):1529-36.
 Abstract
 
Evaluating the Impact of Hepatitis C Virus (HCV) on Highly Active Antiretroviral Therapy-
Mediated Immune Responses in HCV/HIV-Coinfected Women: Role of HCV on Expression
of Primed/Memory T Cells.
 Al-Harthi L, Voris J, Du W, et al 
J Infect Dis. 2006 May 1;193(9):1202-10.
Abstract
 
Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women.
 Richardson JL, Nowicki M, Danley K, et al  
AIDS. 2005 Oct 14;19(15):1659-1667.
 Abstract

Incident hepatitis C virus in women with human immunodeficiency virus infection.
 Augenbraun M, Goedert JJ, Thomas D, et al
Clin Infect Dis. 2003 Nov 15;37(10):1357-64
 Abstract

     Conference Reports, Abstracts, and Posters

 
POSTER
 Vertical Transmission of Hepatitis C Virus and Clinico-epidemiological Characteristics in a Cohort
of HIV/HCV-co-infected Mothers
 O Nieto, E Munoz, M Gonzalez-Tome, et al
(15th CROI)
 PDF Poster     Abstract
 
POSTER
Immune Activation Is Not Associated with Annual Rate of CD4 Decline in HIV/HCV-co-infected
Women
 R Karim, W Mack, G Neuman, et al
 (15th CROI)
 PDF Poster     Abstract

Determinants of HCV RNA Level among HIV/HCV Co-infected Women
 T Shahidyazdan, W Du, M Nowicki,  et al
 [11 CROI}
 Abstract
Alcoholics
 

     Journal Papers, Abstracts, and Commentaries

 
Substance abuse treatment and receipt of liver specialty care among persons coinfected
with HIV/HCV who have alcohol problems.
Palepu A, Cheng DM, Kim T, et al
 J Subst Abuse Treat. 2006 Dec;31(4):411-7.
Abstract

Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (hiv-1) infections
in alcoholics.
Prakash O, Mason A, Luftig RB, Bautista AP.
Front Biosci 2002 Jul 1;7:E286-300
 Abstract

  
Drug Users